The economic evaluation of sunitinib and sorafenib in mRCC patients in the Czech Republic
| Authors | |
|---|---|
| Year of publication | 2009 |
| Type | Article in Periodical |
| Magazine / Source | Value in Health |
| MU Faculty or unit | |
| Citation | |
| Field | Oncology and hematology |
| Keywords | mRCC; sorafenib; sunitinib |